BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8180111)

  • 1. Stimulatory effect of vasoactive intestinal peptide (VIP) on the secretory activity of dispersed rat adrenocortical cells. Evidence for the interaction of VIP with ACTH receptors.
    Mazzocchi G; Malendowicz LK; Nussdorfer GG
    J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):507-10. PubMed ID: 8180111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway.
    Mazzocchi G; Rebuffat P; Meneghelli V; Malendowicz LK; Tortorella C; Gottardo G; Nussdorfer GG
    Peptides; 1999; 20(5):589-94. PubMed ID: 10465510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that endogenous vasoactive intestinal peptide (VIP) plays a role in the maintenance of the growth and steroidogenic capacity of rat adrenal zona glomerulosa.
    Rebuffat P; Nowak KW; Tortorella C; Musajo FG; Gottardo G; Mazzocchi G; Nussdorfer GG
    J Steroid Biochem Mol Biol; 1994 Oct; 51(1-2):81-8. PubMed ID: 7947354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucagon and glucagon-like peptide-1 on glucocorticoid secretion of dispersed rat adrenocortical cells.
    Andreis PG; Malendowicz LK; Neri G; Tortorella C; Nussdorfer GG
    Life Sci; 1999; 64(24):2187-97. PubMed ID: 10374908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide stimulates adrenal aldosterone and corticosterone secretion.
    Cunningham LA; Holzwarth MA
    Endocrinology; 1988 May; 122(5):2090-7. PubMed ID: 3359977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stimulatory effect of vasoactive intestinal peptides on the cortisol production of guinea pig Zona fasciculata cells: an extra-ACTH regulatory model of the adrenocortical function.
    Fang VS; Juan CC; Hsu YP; Won JG; Ho LT
    Chin J Physiol; 2001 Jun; 44(2):73-9. PubMed ID: 11530947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pituitary adenylate-cyclase activating peptide (PACAP) on the rat adrenal secretory activity: preliminary in-vitro studies.
    Andreis PG; Malendowicz LK; Belloni AS; Nussdorfer GG
    Life Sci; 1995; 56(2):135-42. PubMed ID: 7823760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide stimulates rat adrenal glucocorticoid secretion, through an ACTH receptor-dependent activation of the adenylate cyclase signaling pathway.
    Mazzocchi G; Rebuffat P; Gottardo L; Nussdorfer GG
    Horm Metab Res; 1998 May; 30(5):241-3. PubMed ID: 9660080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoactive intestinal peptide stimulation of aldosterone secretion by the rat adrenal cortex may be mediated by the local release of catecholamines.
    Hinson JP; Kapas S; Orford CD; Vinson GP
    J Endocrinol; 1992 May; 133(2):253-8. PubMed ID: 1613427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic effect of vasoactive intestinal peptide (VIP).
    Haidan A; Hilbers U; Bornstein SR; Ehrhart-Bornstein M
    Peptides; 1998; 19(9):1511-7. PubMed ID: 9864057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexins stimulate corticosterone secretion of rat adrenocortical cells, through the activation of the adenylate cyclase-dependent signaling cascade.
    Malendowicz LK; Tortorella C; Nussdorfer GG
    J Steroid Biochem Mol Biol; 1999; 70(4-6):185-8. PubMed ID: 10622406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that endogenous vasoactive intestinal peptide (VIP) is involved in the regulation of rat pituitary-adrenocortical function: in vivo studies with a VIP antagonist.
    Nowak M; Markowska A; Nussdorfer GG; Tortorella C; Malendowicz LK
    Neuropeptides; 1994 Nov; 27(5):297-303. PubMed ID: 7862261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro and in-vivo studies of the effects of arginine-vasopressin on the secretion and growth of rat adrenal cortex.
    Mazzochi G; Malendowicz LK; Meneghelli V; Gottardo G; Nussdorfer GG
    Histol Histopathol; 1995 Apr; 10(2):359-70. PubMed ID: 7599433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of adrenomedullin and its fragment 22-52 on basal and ACTH-stimulated secretion of cultured rat adrenocortical cells.
    Ziolkowska A; Budzynska K; Trejter M; Tortorella C; Belloni AS; Malendowicz LK
    Int J Mol Med; 2003 May; 11(5):613-5. PubMed ID: 12684698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal vasoactive intestinal peptide participates in neonatal corticosteroid production in the rat.
    Bodnar M; Sarrieau A; Deschepper CF; Walker CD
    Am J Physiol; 1997 Sep; 273(3 Pt 2):R1163-72. PubMed ID: 9321900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VIP antagonist demonstrates differences in VIP- and PHI-mediated stimulation and inhibition of ACTH and corticosterone secretion in rats.
    Alexander LD; Sander LD
    Regul Pept; 1995 Nov; 59(3):321-33. PubMed ID: 8577937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroidogenic effect of peptide histidine-isoleucine (PHI) in vitro: comparison with VIP.
    Nowak KW; Malendowicz LK
    Endocr Res; 1998; 24(3-4):759-62. PubMed ID: 9888573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of vasoactive intestinal peptide (VIP) on amphibian adrenocortical function, in vitro.
    Leboulenger F; Perroteau I; Netchitailo P; Lihrmann I; Leroux P; Delarue C; Coy DH; Vaudry H
    Peptides; 1984; 5(2):299-303. PubMed ID: 6473157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual effect of prolonged vasoactive intestinal peptide (VIP) administration on the adrenal growth and corticosterone secretion in the rat.
    Malendowicz LK; Nussdorfer GG
    Neuropeptides; 1993 Aug; 25(2):145-50. PubMed ID: 8413859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic polypeptide stimulates rat adrenal glucocorticoid secretion by activating the adenylate cyclase-dependent signaling pathway.
    Rebuffat P; Malendowicz LK; Meneghelli V; Macchi V; Nussdorfer GG
    Life Sci; 1998; 62(14):1217-22. PubMed ID: 9570336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.